EMEA-002091-PIP01-16 - paediatric investigation plan

amlodipine

perindopril

Key facts

• Active Substance:
  • amlodipine
  • perindopril
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0110/2017
• PIP number:
  EMEA-002091-PIP01-16
• Pharmaceutical form(s):
  Tablet
• Condition(s) / indication(s):
  Treatment of hypertension
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  11/04/2017

Decision

P/0110/2017: EMA decision of 11 April 2017 on the granting of a product specific waiver for amlodipine / perindopril (EMEA-002091-PIP01-16)

AdoptedReference Number: EMA/196235/2017